Annual Drug Patent Expirations for KERYDIN
Kerydin is a drug marketed by Anacor Pharms Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for KERYDIN.
The generic ingredient in KERYDIN is tavaborole. One supplier is listed for this compound. Additional details are available on the tavaborole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
